Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Number of holders
-
147
-
Total 13F shares, excl. options
-
54,652,539
-
Shares change
-
+1,630,665
-
Total reported value, excl. options
-
$819,732,570
-
Value change
-
+$37,421,908
-
Put/Call ratio
-
83.09%
-
Number of buys
-
81
-
Number of sells
-
-60
-
Price
-
$15
Significant Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q3 2017
188 filings reported holding SGMO - SANGAMO THERAPEUTICS, INC - Common Stock as of Q3 2017.
SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) has 147 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54,652,539 shares
of 294,683,714 outstanding shares and own 18.55% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6,733,161 shares), WASATCH ADVISORS INC (5,190,789 shares), VANGUARD GROUP INC (3,931,954 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3,200,000 shares), STATE STREET CORP (2,890,810 shares), FMR LLC (2,843,889 shares), BAKER BROS. ADVISORS LP (2,113,376 shares), D. E. Shaw & Co., Inc. (1,604,555 shares), Casdin Capital, LLC (1,400,000 shares), and Invesco Ltd. (1,379,205 shares).
This table shows the top 147 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.